Barring unforeseen events; growth vs. PY in cc
Group Sales expected to grow low to mid single digit Core operating income expected to grow mid single digit, ahead of sales ---------- --------------------------------------------------------- Innovative Sales expected to grow mid single digit Medicines Core operating income revised upwards from expected to "grow mid to high single digit" to "grow high single digit" Sandoz Sales expected to decline low to mid single digit Core operating income revised downwards from expected to "decline low to mid-teens" to "decline mid to high teens"
Our guidance assumes that…